FDA Approved: GABAPENTIN — Original Application (Creekwood Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Creekwood Pharmaceuticals LLC's gabapentin under an Abbreviated New Drug Application, authorizing the generic product's market entry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Postherpetic Neuralgia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

ORIG AP for GABAPENTIN (GABAPENTIN)